BRCA-related ovarian carcinoma: Another piece of the puzzle?

Research output: Contribution to journalReview articlepeer-review

15 Scopus citations

Abstract

The author comments on a report in this issue of Cancer by investigators who used clinical response endpoints and chemoresistance testing to confirm the improved survival of women with hereditary ovarian carcinoma compared with women who had sporadic ovarian carcinoma. The possible use of BRCA mutation status to improve patient care, the future of translational research, and the difficulties in proceeding with large-scale prospective trials are among the topics discussed.

Original languageEnglish
Pages (from-to)2127-2129
Number of pages3
JournalCancer
Volume97
Issue number9
DOIs
StatePublished - May 1 2003

Keywords

  • BRCA1 Protein/genetics
  • BRCA2 Protein/genetics
  • Disease-Free Survival
  • Female
  • Germ-Line Mutation
  • Humans
  • Ovarian Neoplasms/genetics
  • Survival Rate

Fingerprint

Dive into the research topics of 'BRCA-related ovarian carcinoma: Another piece of the puzzle?'. Together they form a unique fingerprint.

Cite this